BioAffinity Technologies Names Michael Dougherty as Chief Financial Officer

bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, today announced that Michael Dougherty has joined... | May 1, 2023

Related Keywords

United States ,American ,Maria Zannes ,Michael Dougherty ,Michael Edwards ,American Institute Of Certified Public Accountants ,Linkedin ,Laboratory Developed Test ,Medisystems Corporation ,Affinity Technologies Inc ,Idera Inc ,University Of Texas At San Antonio ,Twitter ,Precision Pathology Services ,Nasdaq ,Affinity Technologies ,Chief Financial Officer ,Affinity Technologies President ,Chief Executive Officer Maria ,Alexa Business Domains ,Chief Financial ,Operating Officer ,Amazon Pay ,Russell Investments ,Chartered Global Management Accountant ,American Institute ,Certified Public ,Precision Pathology ,Bioaffinity Technologies ,Nc Stock Exchange ,News ,Information ,Press Release ,Ioaffinity ,Biotechnology ,Company ,Ocused ,N ,The ,Need ,Or ,Accurate ,Tests ,Detection ,F ,Oday ,Nnounced ,Hat ,Michael ,Dougherty ,As Biaf Us09076w1099 ,